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(ERCP) was first reported in 1968 and was soon
considered a safe and direct technique for evaluating
biliary and pancreatic diseases. It is now a commonly
performed endoscopic procedure. ERCP has evolved
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ABSTRACT
Background:  This study retrospectively evaluated post-endoscopic retrograde cholangio-
pancreatography (ERCP) complications at Cipto Mangunkusumo hospital in order to improve
management of a subsequent prospective study of post-ERCP complications.
Method: The indications, findings, diagnostic or therapeutic procedure, cannulation, devices used
during the procedure, and complications of patients treated consecutively with ERCP between January
2004 and November 2008 were evaluated retrospectively.
Results: Of 176 ERCP patients who were initially evaluated, 38% had undergone diagnostic ERCP
and 62% therapeutic ERCP. The median age of the patients was 49 years (range 18–80 years);
95 (53.9%) were male. Only 54 of these 176 procedures could be evaluated for post-ERCP complications.
A computed tomographic abdominal scan or magnetic resonance cholangio-pancreatography was
performed in 23 (42.6%) patients and a biliary sphincterotomy in 14 (25.9%) patients. The overall
complication rate was 33.3%: 14.8% after diagnostic ERCP and 18.5% after therapeutic ERCP.
The complications after diagnostic ERCP were pancreatitis in 3 (15%) patients, cholangitis in 3 (15%)
patients, hemorrhage in 1 (5%) patient, pancreatitis and hemorrhage in 1 (5%)
patient; the complications after therapeutic ERCP were pancreatitis in 6   (17.6%) patients, cholangitis in
3 (8.8%) patients, hemorrhage in none, and concomitant pancreatitis with hemorrhage in 1 (2.9%)
patient. No significant difference was observed between the complication rates and the type of ERCP
performed.
Conclusion: There were no differences in the complications after diagnostic and therapeutic ERCP.
As our study shows the post-ERCP complication rate to be higher than those of other large retrospective
and prospective studies, we must evaluate it in a prospective study.
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from a diagnostic procedure to an almost exclusively
therapeutic procedure. Other imaging techniques, such
as ultrasonography, computed tomography (CT),
magnetic resonance imaging, endoscopic ultrasono-
graphy, and intraoperative cholangiography, provide
diagnostic information that allows the selection of
patients for therapeutic ERCP.1,2
At Cipto Mangunkusumo hospital, several studies
of ERCP procedures have been performed since 1987.
In 1987, a review of 520 patients was conducted, and
in 1991, Lesmana et al reported 34 patients who had
undergone parendoscopic endoprosthesis procedures
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and 84 patients who had undergone endoscopic
sphincterotomy and stone extraction. Clinical
descriptions of 24 patients with obstructive jaundice
from August 1989 to August 1990 were reported by
Waspodo.3,4,5
Because ERCP has since evolved from
a diagnostic to a therapeutic procedure, a prospective
study of the complications observed after these ERCP
procedures is required. Preparatory to such a study,
we performed a retrospective study of post-ERCP
complications that had occurred between January 2004
and November 2008 to evaluate any differences
between the diagnostic and therapeutic procedures and
to improve the management of the subsequent
prospective study.
METHOD
A retrospective study was conducted at the Cipto
Mangunkusumo hospital for the period from January
2004 to November 2008. In total, 199 consecutive
ERCPs were performed during the study period;
176 of these could be evaluated, and 54 of
the procedures met the criteria for inclusion in
the evaluation of post-ERCP complications. Data on
the patients’ characteristics, ERCP indications and
findings, cannulation, period of hospitalization, and
complications were collected retrospectively. These
data were entered into a database for subsequent
processing and analysis.
Post-ERCP complications were defined as any
adverse effects related to the ERCP that prolonged
the patient’s hospitalization or required the
readmission of a previously discharged patient.6 Acute
pancreatitis was defined as the new onset of
abdominal pain, with an elevated amylase level at least
three times higher than the upper limit of the normal
range for more than 24 hours after the procedure,
requiring hospitalization for more than one night.
The grading system used for the major
complications of ERCP and endoscopic sphincterotomy
was:6,7 (1) mild: serum amylase at least three times
the normal level for more than 24 hours after
the procedure, or the readmission of the patient or
prolongation of the planned hospital stay by 2–3 days;
(2) moderate: hospitalization of 4–10 days; (3) severe:
hospitalization for more than 10 days, haemorrhagic
pancreatitis, phlegmon or pseudocyst, or intervention
(percutaneous drainage or surgery).
Bleeding was defined as clinical evidence of
haemorrhage, with a reduction in haemoglobin of more
than 2 g/dL or the need for a blood transfusion.
Cholangitis was defined as a temperature higher than
38 °C for more than 24 hours that was considered to
have a biliary etiology.6,7 Any intensive-care-unit
admission after the procedure was graded as a severe
complication. ERCP was defined as therapeutic when
an endoscopic sphincterotomy, pre-cut sphincterotomy,
drainage, stricture dilatation, stent exchange, sphincter
of Oddi manometry, or biliary stone removal was
performed at the same time, singly or in combination.6,7
The statistical analysis was performed using SPSS
version 10.0. The diagnostic and therapeutic ERCP
complications were compared using the ÷2 test or
Fisher’s exact test. All tests of significance were
two-tailed and p < 0.05 was considered significant.
RESULTS
In total, 199 ERCPs were performed during
the study period, of which 176 were initially evaluated.
The median age of the patients was 49 years (range
18–80 years); 95 (53.9%) were male. The ethnic
distribution was 71 (40.3%) Javanese patients,
28 (15.9%) Betawinese patients, 23 (13.1%)
Sundanese patients, 19 (10.8%) Batak patients,
11 (6.3%) Minangkabau patients, 7 (3.9%) patients
from Sulawesi (Buginese, Makassarese or Torajas),
and 17 (9.7%) patients from other ethnic groups.
The indications for ERCP were presented in figure 1.
Therapeutic ERCP was performed in 109 (62%)
patients and diagnostic ERCP in 67 (38%) patients.
ERCP failed in 18 (10.2%) patients because of
unsuccessful cannulation. Failure of cannulation was
predominantly caused by a mass in the papilla vateri.
Endoscopic sphincterotomy (EST) was performed in
48 (44.1%) patients undergoing ERCP (table 1).
Figure 1. Indications for ERCP in 176 patients
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Table 1. Therapeutic procedures in 109 patients 
Type of procedure n % 
EST 9 8.3 
EST and stone extraction  27 24.8 
EST and stone extraction and stent 6 5.5 
EST and biliary stent 4 3.7 
EST and stricture dilatation 1 0.9 
NBD and EST dilatation 1 0.9 
Biliary stent/stent removal  36 33 
Dilatation and stent 2 1.8 
Biopsy and stent 8 7.3 
Biopsy  15 13.8 
Total 109 100 
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Of the 176 patients who underwent ERCP  
procedures, only 54 could be evaluated for post-ERCP  
complications (table 2). Of these patients, 29 (53.7%)  
were male. Their median age was 47 years (range  
26-80 years). Twenty-three (13%) patients had been  
referred from other hospitals. A CT abdominal scan or  
magnetic resonance cholangiopancreatography  






ERCP has evolved from a purely diagnostic  
procedure to a therapeutic procedure with  
the introduction of non-invasive investigative tools such  
as MRCP. Most of the ERCP procedures examined in  
this study were therapeutic (62%). In 1990, Waspodo  
et al reported that the duration of the chief complaint  
requiring hospitalization was 2.7 weeks for stone  
diseases and 3.9 weeks for malignancies. The period  
of hospitalization until definitive therapy was 20 days  
for stone diseases and 18.4 days for malignancies.5 
Prophylactic antibiotics were given to 75% of 
patients, usually second-generation cephalosporin.  
Eleven (20.4%) patients had co-morbidities such as  
diabetes mellitus (eight patients), ischaemic heart  
disease (one patient), atrial fibrillation (one patient), and  
renal impairment (one patient); 23 (42.6%) patients had  
co-morbidities such as anemia of   iron-deficiency,  
hypokalemia, hypoalbuminemia, hypertension,  
pulmonary obstructive disease, and others; 20 (37%)  
patients had no co-morbidity. Only one patient was  
taking anti-platelet drugs for an underlying disease.  
 The mean duration of the chief complaint requiring  
hospitalization was 30.6 ± 29.3 days (median 25.5, range  
1-120 days). The period of hospitalization until  
the ERCP procedure was 11.5 ± 8.5 days (median 10,  
range 1-42 days). Adverse event while under  
anaesthesia were not well reported. Table 2 shows  
the major complications in the 54 patients and  
a comparison of the complications after diagnostic and  
therapeutic ERCPs. Table 4 shows the types of  
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The post-ERCP complication rate in the present 
series of patients was higher than those of other 
studies; at 33.3%, the overall complication rate higher 
than that of a prospective Singaporean study 9.8%, 
the study of Lesmana 10%, and other studies 
6.6-8.7%.3,6,7,8 However, as this finding refers 
to only 54 (30.7%) of 176 ERCP procedures, a 
prospective study is required. As mentioned above, the 
duration of the chief complaint and the period of 
hospitalization before definitive therapy did not change 
greatly between 1990 and this study, in the future 
denifitive therapy must be done earlier. 
There  was  no  significant  difference  in 
the complication rates of the diagnostic and 
therapeutic ERCPs. This finding is consistent with those 
of a retrospective survey in the USA by Male et al6 
and a prospective study in Singapore by Ong et al,6 but is 
in contrast to those of British and Italian studies in 
which therapeutic ERCP was associated with 3-4 fold 
higher complication rates.6 
The reported incidence of post-ERCP pancreatitis  
ranges from 0% to 40%, with the reported incidence  
in most prospective series ranging from 1.8% to 
7.2%.7,8,9 This variation is probably attributable to  
differences in the definition of pancreatitis, the  
methods of data collection, and the indications for  
ERCP. In the present study, acute pancreatitis was the  
most common complication (16.6% of patients).  
Another two patients had mild pancreatitis with  
concomitant hemorrhage. Four (7.4%) cases of  
pancreatitis were mild, three (5.5%) were moderate,  
and two (3.7%) were severe. These incidences are 
43  
 
Table 2. Major complications in 54 patients: comparison of 
diagnostic and therapeutic ERCPs 
ERCP 
Complication  Diagnostic  
n = 20 (%) 
Therapeutic  
n = 34 (%) 
p 
Pancreatitis 3 (15) 6 (17.6) 1.00 
Cholangitis 3 (15) 3 (8.8) 0.66 
Haemorrhage 1 (5) 0 0.37 
Pancreatitis and 
haemorrhage 1 (5) 1 (2.9) 1.00 
Total 8 (40) 10 (29.4)  
Table 3. Grades of pancreatitis complications 
ERCP 
Pancreatitis  
Diagnostic  Therapeutic  
Total 
 Mild 3 1 4 
 Moderate 2 1 3 
 Severe 1 1 2 
Total 6 3 9 
 
Table 4. Therapeutic procedures in 34 patients 
Type of procedure n % 
Endoscopic sphincterotomy  2 5.9 
EST and stone extraction  9 26.5 
EST, stone extraction, and stent 2 5.9 
EST and stricture dilatation 1 2.9 
Biliary stenting/stent removal  18 52.9 
Dilatation and stenting 1 2.9 
Biopsy  1 2.9 
Total 34 100 
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higher than those of two large prospective studies
reported by Freeman et al and Loperfido et al.7,8 In
these two studies, which considered the therapeutic
procedure only, the pancreatitis complication rates were
5.4% and 1.6%, respectively. In a prospective study,
Cheng et al reported that pancreatitis accounted for
15.1% of post ERCP complications.10 In a study
undertaken in Singapore, in which both diagnostic and
therapeutic procedures were considered, pancreatitis
occurred in 5.4% of patients: mild in 2.3%, moderate
in 2.8%, and severe in 0.4%.6
In this study, the risk of pancreatitis was similar
after diagnostic and therapeutic ERCP. This is
consistent with the findings of the prospective
Singaporean study of Ong et al.6 The risk factors
identified for procedure-related pancreatitis included
those related to patient characteristics, such as younger
age, suspected dysfunction of the sphincter of Oddi,
a history of ERCP-related pancreatitis, and recurrent
pancreatitis, and factors related to the endoscopic
technique, such as pancreatic duct opacification, small
bile duct, multiple cannulation attempts or difficult
cannulation, development of abdominal pain during
the procedure, pre-cut sphincterotomy, and pancreatic-
duct brushing for cytology.6,9,10,11,12
The incidence of post-ERCP haemorrhage in
a systematic survey of prospective studies was
1.34%.13 Study by Ong et al, showed the incidence of
hemorrhage was only 0.8%.6 The reported incidence
of hemorrhage after sphincterotomy ranges from
0.76% to 2%.1 In our study, procedure-related
haemorrhage occurred in three (5.5%) patients, two
after diagnostic ERCP and one after sphincterotomy
and stenting procedures.
The rate of post-ERCP cholangitis was 0.7–1.0%
in several studies.1,13 The rate of cholangitis seems to
have been slightly higher (2.3%) in the study by Ong
et al, although routine antibiotics were given before
the procedure. In this study, cholangitis occurred in six
(11.1%) patients, all of whom had been given second-
generation cephalosporin as the prophylactic antibiotic.
Two of them died of severe cholangitis. Of these two
patients, ERCP had demonstrated cholangiocarcinoma
and Klatskin tumor. Two patients underwent
sphincterotomy. Of these two patients, ERCP showed
multiple stones in the common bile duct (CBD) and
Klatskin tumor. Another two patients underwent
diagnostic ERCPs: one patient was diagnosed with
suspected carcinoma in the head of the pancreas and
the other with total obstruction of the CBD, with
dilatation and irregularity of the main pancreatic duct
(MPD). Mallery et al and Freeman et al presumed
that the risk factors for post-ERCP cholangitis were
failed or incomplete biliary drainage, a percutaneous
procedure, or malignant jaundice.1,15 Four of our
patients had malignant jaundice, which might have
contributed to incomplete biliary drainage and might
have precipitated cholangitis.
In this study, three (5.5%) patients died from
procedure-related causes: severe cholangitis in two
patients and hemorrhage in one patient. The overall
mortality rate after diagnostic ERCP is roughly 0.2%
in general. The death rate after therapeutic ERCP is
twice as high (0.4–0.49%).1 A recent survey of
prospective studies reported a death rate of  0.33%
after the ERCP procedure.13
One patient who died from hemorrhage was
a 53-year-old man. A CT-scan showed biliary
cirrhosis and a liver biopsy revealed chronic hepatitis;
he was negative for hepatitis B surface antigen and
hepatitis C virus. His serum á-fetoprotein level was
3.9 ng/mL, total serum bilirubin was 22.3 mg/dL,
albumin was 3.3 g/dL, globulin was 2.4 g/dL,
prothrombin time (PT) was 30.4 (control = 12.7), and
activated partial thromboplastin time (APTT) was 75.4
(control = 36.5). This was corrected with fresh frozen
plasma and an injection of vitamin K. Before ERCP,
his PT was 10.2 (control = 13.2) and his APTT was 34
(control = 36.5). ERCP revealed total obstruction of
the distal CBD, a normal MPD, and unsuccessful
cannulation with wire, because the wire was always
directed to the pancreatic duct. The patient died four
days after the procedure.
The risk factors for hemorrhage identified by
multivariate analysis included coagulopathy at the time
of the examination, the use of anti-coagulants within
72 hours of the sphincterotomy, the presence of acute
cholangitis or papillary stenosis, the use of pre-
cut sphincterotomy, and the inexperience of the
endoscopist.1,6
Cholangitis was suggested as the cause of death in
a 44-year-old man who had undergone ERCP with an
indication of dilated CBD. ERCP revealed stenosis/
stricture of the distal CBD with proximal dilatation,
IHBD dilatation, and a non-enlarged MPD, and he was
diagnosed with cholangiocarcinoma. Seven days after
the procedure, he suffered from sepsis and low blood
pressure, and was unconscious for four days. His family
then discharged him from hospital without permission.
The other death was of a 51-year-old woman with
abdominal ultrasonography CT scan suggestive of
carcinoma in the head of the pancreas and liver
metastasis. Anemia and hypoalbuminemia were
comorbidities. ERCP was performed twice. During
the first procedure, the CBD was stented.
The diagnosis was Klatskin tumour, with a differential
diagnosis of carcinoma of the head of the pancreas
and cholangiocarcinoma. A second ERCP, performed
three months later. The result was migration of
the stent to the proximal CBD and a plastic stent was
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inserted beside the first stent, with the end of the stent
in the right IHBD, and bile with pus was expelled from
the stent. Seven days after the procedure, the patient’s
temperature was high and she became somnolent;
she died 11 days after the procedure from severe
cholangitis. Because this was a retrospective study,
many ERCP procedures had been evaluated
incompletely and a long time ago, and some factors
related to the endoscopic technique could not be
investigated. All these factors should be considered in
our forthcoming prospective study.
CONCLUSION
There were no differences in the complications
after diagnostic and therapeutic ERCP. Our study
showed that the post-ERCP complication rate was
higher than those of other large retrospective or
prospective studies, but because only 30.7% of
procedures could be evaluated, a prospective study is
required for a more complete evaluation.
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